🔎 Trials Near Me

Hjem › Multipelt myelom › Florida › Jacksonville

Multipelt myelom kliniske forsøg i Jacksonville, FL

18 studier for Multipelt myelom søger deltagere på steder i og omkring Jacksonville (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Rekrutterer
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06630104

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 3
  • Mayo Clinic Jacksonville, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 3
  • Mayo Clinic Jacksonville, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07258511

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

RekruttererFase 1
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06465316

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

RekruttererFase 3
  • Baptist MD Anderson Cancer Center, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 2
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT06297226

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

RekruttererFase 1
  • Mayo Clinic Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT06375044

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

RekruttererFase 1
  • Mayo Clinic Hospital - Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

RekruttererFase 1/2
  • Research Site, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT05850234

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

RekruttererFase 2
  • Mayo Clinic - Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07284758

Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

RekruttererFase 2
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 14. jul. 2026 · NCT05847569

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

RekruttererFase 3
  • Mayo Clinic in Florida, Jacksonville
Alle aldre · Alle køn · Opdateret 10. jun. 2026 · NCT05561387

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

RekruttererFase 2
  • Mayo Clinic in Florida, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 20. apr. 2026 · NCT05969860

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

RekruttererFase 1
  • Cancer Specialists, LLC, Jacksonville
Alder 18 og opefter · Alle køn · Opdateret 1. nov. 2023 · NCT03110822

Multipelt myelom forsøg i andre byer

Andre studier i Jacksonville

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.